Valion Bio (VBIO) Non-Current Assets (2020 - 2026)
Valion Bio (VBIO) posted Non-Current Assets of $29.09 million for Q2 2026, up 991.2% from $2.67 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio's Non-Current Assets came in at $18.6 million.
- Annual Non-Current Assets shows a four-year compound annual growth rate of 123.4% (FY2021 to FY2025).
- In prior years, Valion Bio's Non-Current Assets was $168,000 in FY2024 (-66.7%), $505,000 in FY2023 (-11.2%), $569,000 in FY2022 (-23.8%) and $747,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets in data going back to Q4 2021.
- On a year-over-year basis, Non-Current Assets increased in three of the last five quarters, with growth averaging 458.4%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2026, with growth of 991.2%; the weakest was Q2 2024, with a decline of 79.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | 29.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.09 Mn |
| Mar 31, 2026 | 29.56 Mn |
| Dec 31, 2025 | 18.60 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 231,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Dec 31, 2023 | 505,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 596,000.00 |
| Mar 31, 2023 | 619,000.00 |
| Dec 31, 2022 | 569,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 654,000.00 |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 747,000.00 |
| Dec 31, 2020 | 34,000.00 |
API Access
Valion Bio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();